Letter from the EditorWelcome to the 24th issue of Vaccines Beat!

Welcome to the 24th issue of Vaccines Beat!

It is truly a pleasure to celebrate two consecutive years of publication and to have you as part of this growing global community dedicated to vaccines, vaccinology, and public health. Thank you for your continued support and engagement throughout this journey.

In our Coffee with the Expert section, we are honored to feature Dr. Clarisse Ingabire, Global Livestock Specialist at the World Bank. A veterinarian, public health specialist, and leading advocate for the One Health approach, Dr. Ingabire brings more than two decades of experience in animal health, food security, and sustainable livestock development. In this insightful interview, “One Health: The Journey from Cattle Herds to Global Policy,” she discusses the critical connections between animal health, vaccination, food security, economic development, and global public health.

In our Editor’s Corner, we explore “Drones and Vaccines: Are We Ready to Rethink How We Deliver Life-Saving Immunization?” As technology continues to reshape healthcare, drone-based vaccine delivery is emerging as a promising solution to overcome geographic and logistical barriers. The challenge is no longer whether drones can deliver vaccines effectively, but how quickly health systems can integrate this innovation to expand access and improve immunization equity worldwide.

Our Best Practice section examines “Fractional Dosing in Vaccinology: From Emergency Strategy to Precision Public Health Tool.” Once considered primarily a response to vaccine shortages and outbreaks, fractional dosing is increasingly recognized as a valuable strategy to expand vaccine coverage, improve equity, optimize resource utilization, and maximize population-level impact.

In the Guest Contributor section, Bruno Speder, MSc, a bioengineer and health economist at Aletheia Life Science, discusses “The Use of Prior Knowledge in Early Vaccine Development.” Drawing on his extensive experience in global regulatory affairs and vaccine development, including interactions with major regulatory agencies such as the FDA and EMA, Bruno highlights how existing scientific, clinical, and regulatory evidence can accelerate vaccine innovation, streamline development, and support more efficient decision-making.

As always, this issue also features carefully curated summaries of the Latest Scientific Publications, together with the most relevant and timely News and Alerts from the world of vaccines and infectious diseases.

We hope you find this June 2026 Second Anniversary Issue both informative and engaging. We look forward to continuing our shared commitment to advancing immunization, strengthening public health, and contributing to a healthier and more resilient world.

TRENDING